Publications in collaboration with researchers from University of California Los Angeles (3)

2026

  1. Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer

    The New England journal of medicine, Vol. 395, Núm. 7, pp. 660-670

2018

  1. Abemaciclib in combination with single-agent options in patients with stage IV non–small cell lung cancer: A phase Ib study

    Clinical Cancer Research, Vol. 24, Núm. 22, pp. 5543-5551

2015

  1. A Phase Ib dose-escalation study of the oral pan-PI3K inhibitor buparlisib (BKM120) in combination with the oral MEK1/2 inhibitor trametinib (GSK1120212) in patients with selected advanced solid tumors

    Clinical Cancer Research, Vol. 21, Núm. 4, pp. 730-738